Medicine's Daniel Spratt discusses new AI prostate tool to analyze biopsy images

AI prostate tool analyses biopsy images to predict metastasis and mortality risks

Digital Health News: Daniel Spratt, chair of radiation oncology at Case Comprehensive Cancer Center, commented on a new AI-enabled prostate cancer risk assessment tool has been developed to analyze biopsy images and generate long-term predictions for metastasis and cancer-specific mortality in men diagnosed with localized prostate cancer. “The tool captures complex patterns within biopsy tissue and translates them into clinically meaningful risk predictions that help identify which patients require closer monitoring or intensified therapy," said Spratt.